On Tuesday, Resmed Inc (NYSE: RMD) opened higher 0.87% from the last session, before settling in for the closing price of $243.61. Price fluctuations for RMD have ranged from $140.81 to $260.49 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 12.49% over the past five years. Company’s average yearly earnings per share was noted 21.60% at the time writing. With a float of $145.63 million, this company’s outstanding shares have now reached $146.90 million.
Let’s look at the performance matrix of the company that is accounted for 9980 employees. In terms of profitability, gross margin is 57.2%, operating margin of 29.5%, and the pretax margin is 28.62%.
Resmed Inc (RMD) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Medical Instruments & Supplies industry is another important factor to consider. The insider ownership of Resmed Inc is 0.79%, while institutional ownership is 60.12%. The most recent insider transaction that took place on Nov 01 ’24, was worth 16,698. In this transaction Global General Counsel of this company sold 69 shares at a rate of $242.00, taking the stock ownership to the 10,443 shares. Before that another transaction happened on Nov 01 ’24, when Company’s Officer proposed sale 69 for $242.00, making the entire transaction worth $16,698.
Resmed Inc (RMD) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 21.60% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 17.00% during the next five years compared to 19.83% growth over the previous five years of trading.
Resmed Inc (NYSE: RMD) Trading Performance Indicators
Check out the current performance indicators for Resmed Inc (RMD). In the past quarter, the stock posted a quick ratio of 1.91. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.50. Likewise, its price to free cash flow for the trailing twelve months is 26.66.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 7.54, a number that is poised to hit 2.31 in the next quarter and is forecasted to reach 10.36 in one year’s time.
Technical Analysis of Resmed Inc (RMD)
Resmed Inc (NYSE: RMD) saw its 5-day average volume 1.14 million, a positive change from its year-to-date volume of 1.05 million. As of the previous 9 days, the stock’s Stochastic %D was 35.24%. Additionally, its Average True Range was 6.25.
During the past 100 days, Resmed Inc’s (RMD) raw stochastic average was set at 81.81%, which indicates a significant increase from 41.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 34.13% in the past 14 days, which was lower than the 37.41% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $243.01, while its 200-day Moving Average is $210.51. Nevertheless, the first resistance level for the watch stands at $247.74 in the near term. At $249.74, the stock is likely to face the second major resistance level. The third major resistance level sits at $252.97. If the price goes on to break the first support level at $242.51, it is likely to go to the next support level at $239.28. The third support level lies at $237.28 if the price breaches the second support level.
Resmed Inc (NYSE: RMD) Key Stats
There are currently 146,796K shares outstanding in the company with a market cap of 36.07 billion. Presently, the company’s annual sales total 4,685 M according to its annual income of 1,021 M. Last quarter, the company’s sales amounted to 1,225 M and its income totaled 311,360 K.
